Clinical Trials Directory

Trials / Terminated

TerminatedNCT04397029

Assessing the Sensitivity of "SureTouch™" in Women Undergoing Diagnostic and Screening Mammography

Assessing the Sensitivity of "SureTouch™" in Identifying Clinically Significant Masses in Women Undergoing Diagnostic and Screening Mammography

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
213 (actual)
Sponsor
George Washington University · Academic / Other
Sex
Female
Age
30 Years – 80 Years
Healthy volunteers
Accepted

Summary

Prospective, case-control study being conducted to determine the sensitivity of the SureTouch device in detecting known masses at a pre-determined level of specificity.

Detailed description

This is a single-center, prospective, case-control study being conducted to determine the sensitivity of the SureTouch device in detecting known masses at a pre-determined level of specificity. Results of the mammography will be compared to the SureTouch examination results. Subjects will have between 1 and 3 research visits and 3 follow-up surveys, up to two years from the initial visit. The number of visits will be based upon comparison of the SureTouch examination to conventional breast screening techniques (mammogram and ultrasound).

Conditions

Interventions

TypeNameDescription
DEVICESureTouchThe first group will consist of 70 women who are believed to be free of masses, recruited during a screening mammography appointment. The second group will include 125 women presenting for diagnostic mammography and/or biopsy appointment with known masses identified on mammogram, ultrasound or both. Both groups will receive breast cancer screening with mammography and SureTouch.

Timeline

Start date
2019-01-04
Primary completion
2021-02-10
Completion
2021-02-10
First posted
2020-05-21
Last updated
2022-06-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04397029. Inclusion in this directory is not an endorsement.